SEGURIL Side Effects

6836516-8 | Condition Aggravated, Granulomatous Liver Disease, Hypercalcaemia, Off Label Use
on Jul 05, 2010 Male patient from SPAIN , 62 years of age, was diagnosed with hypercalcaemia, hyperuricaemia, type 2 diabetes mellitus and was treated with Seguril (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, granulomatous liver disease, hypercalcaemia, off label use. Seguril dosage: . During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), METFORMIN (View Metformin Review and Metformin Label ). Patient was hospitalized.

6762026-2 | Granulomatous Liver Disease, Hypercalcaemia
Patient was taking Seguril (View Usage). Patient had the following side effects: granulomatous liver disease, hypercalcaemia on May 28, 2010 from SPAIN Additional patient health information: Male patient , 62 years of age, was diagnosed with portal hypertension, hyperuricaemia and. Seguril dosage: . During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

6760173-2 | Hyperkalaemia, Nodal Rhythm, Renal Failure Acute
Adverse event was reported on May 27, 2010 by a Male patient taking Seguril (View Usage) (Dosage: ) was diagnosed with thrombosis prophylaxis, cardiovascular event prophylaxis, ischaemic cardiomyopathy and. Location: SPAIN , 73 years of age, After Seguril was administered, patient had the following side effects: hyperkalaemia, nodal rhythm, renal failure acute. During the same period patient was treated with MICARDIS HCT (View Micardis Hct Review and Micardis Hct Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), NORVASC (View Norvasc Review and Norvasc Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ). Patient was hospitalized.

6749741-1 | Hyperkalaemia, Hyponatraemia, Somnolence
on May 21, 2010 Female patient from SPAIN , 85 years of age, was diagnosed with hypertension, prophylaxis and was treated with Seguril (View Usage). Patient experienced the following unwanted or unexpected effects: hyperkalaemia, hyponatraemia, somnolence. Seguril dosage: . During the same period patient was treated with ENALAPRIL (View Enalapril Review and Enalapril Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), ADIRO (View Adiro Review and Adiro Label ), ZALDIAR (3 Df Daily Dose:3 Unit(s)) (View Zaldiar Review and Zaldiar Label ). Patient was hospitalized.


6732146-7 | Hyperkalaemia, Nodal Rhythm, Renal Failure Acute
on May 11, 2010 Male patient from SPAIN , 73 years of age, was diagnosed with hypertension, ischaemic cardiomyopathy, thrombosis prophylaxis and was treated with Seguril (View Usage). Patient had the following side effects: hyperkalaemia, nodal rhythm, renal failure acute. Seguril dosage: . During the same period patient was treated with ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), MICARDIS HCT (View Micardis Hct Review and Micardis Hct Label ), NORVASC (View Norvasc Review and Norvasc Label ). Patient was hospitalized.

6716027-0 | Renal Failure Acute
Patient was taking Seguril (View Usage). After Seguril was administered, patient had the following side effects: renal failure acute on Apr 26, 2010 from SPAIN Additional patient health information: Male patient , 59 years of age, was diagnosed with hypertension and. Seguril dosage: . During the same period patient was treated with OLMESARTAN MEDOXOMIL (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ), COLCHICINE (View Colchicine Review and Colchicine Label ). Patient was hospitalized.

6713042-8 | Hyperkalaemia, Renal Failure Acute
Adverse event was reported on Apr 26, 2010 by a Male patient taking Seguril (View Usage) (Dosage: ) was diagnosed with cardiac failure, hypertension, atrial fibrillation (What is atrial fibrillation?), diabetes mellitus and. Location: SPAIN , 85 years of age, Patient experienced the following unwanted or unexpected effects: hyperkalaemia, renal failure acute. During the same period patient was treated with SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), ALDOCUMAR (View Aldocumar Review and Aldocumar Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ). Patient was hospitalized.

6700181-0 | Granulomatous Liver Disease, Hypercalcaemia
on Apr 15, 2010 Male patient from SPAIN , 62 years of age, was diagnosed with portal hypertension, hyperuricaemia and was treated with Seguril (View Usage). Patient had the following side effects: granulomatous liver disease, hypercalcaemia. Seguril dosage: . During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), METFORMIN (View Metformin Review and Metformin Label ). Patient was hospitalized.

6689913-8 | Asthenia, Fatigue, Malaise, Therapeutic Agent Toxicity
on Apr 09, 2010 Male patient from SPAIN , 88 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Seguril (View Usage). After Seguril was administered, patient had the following side effects: asthenia, fatigue, malaise, therapeutic agent toxicity. Seguril dosage: . During the same period patient was treated with DIGOXIN (View Digoxin Review and Digoxin Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), ESCITALOPRAM (View Escitalopram Review and Escitalopram Label ), FINASTERIDE (View Finasteride Review and Finasteride Label ). Patient was hospitalized.

6550063-2 | Encephalopathy, Hyponatraemia
Patient was taking Seguril (View Usage). Patient experienced the following unwanted or unexpected effects: encephalopathy, hyponatraemia on Jan 15, 2010 from SPAIN Additional patient health information: Female patient , 75 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?), prophylaxis, hypertension and. Seguril dosage: . During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), COROPRES (View Coropres Review and Coropres Label ), SINTROM (View Sintrom Review and Sintrom Label ). Patient was hospitalized.

6543677-7 | Hepatitis Acute
Adverse event was reported on Jan 15, 2010 by a Female patient taking Seguril (View Usage) (Dosage: ) was diagnosed with hypertension, arrhythmia (What is arrhythmia?), prophylaxis, cardiac disorder, anaemia and. Location: SPAIN , 76 years of age, Patient had the following side effects: hepatitis acute. During the same period patient was treated with AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), CARDYL (View Cardyl Review and Cardyl Label ), COROPRES (View Coropres Review and Coropres Label ), EPOETIN BETA (View Epoetin Beta Review and Epoetin Beta Label ).

6507765-3 | Encephalopathy
on Dec 14, 2009 Female patient from SPAIN , 71 years of age, was diagnosed with depression (What is depression?), hypertension and was treated with Seguril (View Usage). After Seguril was administered, patient had the following side effects: encephalopathy. Seguril dosage: . During the same period patient was treated with TRANKIMAZIN (View Trankimazin Review and Trankimazin Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), DAFLON (View Daflon Review and Daflon Label ), VALS (View Vals Review and Vals Label ). Patient was hospitalized.

6462753-0 | Disorientation, Hyponatraemia, Nausea, Presyncope, Somnolence
on Nov 24, 2009 Female patient from SPAIN , 84 years of age, was diagnosed with renal failure chronic, musculoskeletal pain, hypertension, rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Seguril (View Usage). Patient experienced the following unwanted or unexpected effects: disorientation, hyponatraemia, nausea (What is nausea?), presyncope, somnolence. Seguril dosage: . During the same period patient was treated with TRANSTEC (View Transtec Review and Transtec Label ), MASDIL (View Masdil Review and Masdil Label ), DIUZINE (View Diuzine Review and Diuzine Label ), METOTREXATO (View Metotrexato Review and Metotrexato Label ), PANTECTA (View Pantecta Review and Pantecta Label ), GELOCATIL (View Gelocatil Review and Gelocatil Label ), FROSINOR (View Frosinor Review and Frosinor Label ), MINITRAN (View Minitran Review and Minitran Label ). Patient was hospitalized.

6462745-1 | Renal Failure Acute
Patient was taking Seguril (View Usage). Patient had the following side effects: renal failure acute on Nov 19, 2009 from SPAIN Additional patient health information: Male patient , 73 years of age, was diagnosed with renal failure chronic and. Seguril dosage: . During the same period patient was treated with GOPTEN (View Gopten Review and Gopten Label ). Patient was hospitalized.

6456677-2 | Haematuria, Thrombocytopenia
Adverse event was reported on Nov 19, 2009 by a Male patient taking Seguril (View Usage) (Dosage: Dosage: 1/2-0-0) was diagnosed with depression (What is depression?) and. Location: SPAIN , 82 years of age, After Seguril was administered, patient had the following side effects: haematuria, thrombocytopenia. During the same period patient was treated with CIPRALEX /DEN/ (1-0-0) (View Cipralex /den/ Review and Cipralex /den/ Label ), URBASON (1/2-0-0) (View Urbason Review and Urbason Label ), TAMSULOSIN (Dosage: 1/2-0-1/2) (View Tamsulosin Review and Tamsulosin Label ), OPONAF (View Oponaf Review and Oponaf Label ), MESTINON (1/2-0-1/2) (View Mestinon Review and Mestinon Label ), ENALAPRIL MALEATE (Dosage: 1/2-0-1/2) (View Enalapril Maleate Review and Enalapril Maleate Label ), FERRO ^SANOL^ (Dosage: 1-1-0) (View Ferro ^sanol^ Review and Ferro ^sanol^ Label ), CALCIUM SANDOZ (Cada 12 Horas) (View Calcium-sandoz Review and Calcium-sandoz Label ). Patient was hospitalized.

6448689-X | Hyperkalaemia, Renal Failure Acute
on Oct 19, 2009 Male patient from SPAIN , 77 years of age, was diagnosed with hypertension and was treated with Seguril (View Usage). Patient experienced the following unwanted or unexpected effects: hyperkalaemia, renal failure acute. Seguril dosage: . During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), RENITEC /NET/ (View Renitec /net/ Review and Renitec /net/ Label ).

5156222-8 | Renal Failure Acute
on Nov 14, 2006 Female patient from , 87 years of age, was diagnosed with cardiac failure congestive, hypokalaemia, arrhythmia (What is arrhythmia?), gout (What is gout?) and was treated with Seguril (View Usage). Patient had the following side effects: renal failure acute. Seguril dosage: . During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), POTASION (View Potasion Review and Potasion Label ), ADIRO (View Adiro Review and Adiro Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), ALOPURINOL (View Alopurinol Review and Alopurinol Label ). Patient was hospitalized.

5076664-9 | Coma Hepatic, Hepatic Encephalopathy
Patient was taking Seguril (View Usage). After Seguril was administered, patient had the following side effects: coma hepatic, hepatic encephalopathy on Aug 02, 2006 from Additional patient health information: Male patient , 78 years of age, . Seguril dosage: . During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ). Patient was hospitalized.

5054761-1 | Hyperkalaemia, Hyponatraemia
Adverse event was reported on Jul 10, 2006 by a Female patient taking Seguril (View Usage) (Dosage: ) . Location: , 76 years of age, Patient experienced the following unwanted or unexpected effects: hyperkalaemia, hyponatraemia. During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), RENITEC (View Renitec Review and Renitec Label ). Patient was hospitalized.

5015531-3 | Encephalopathy
on May 23, 2006 Male patient from , 78 years of age, was diagnosed with oedema, neuropathy, neurotoxicity, alcoholism (What is alcoholism?) and was treated with Seguril (View Usage). Patient had the following side effects: encephalopathy. Seguril dosage: . During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), CELUPAN (View Celupan Review and Celupan Label ). Patient was hospitalized.

4977883-X | Encephalopathy
on Apr 10, 2006 Male patient from , 76 years of age, was diagnosed with prophylaxis, diabetes mellitus, bronchitis chronic, duodenal ulcer and was treated with Seguril (View Usage). After Seguril was administered, patient had the following side effects: encephalopathy. Seguril dosage: . During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), PROTAMIN ZINC INSULIN (Dose: 26 Ut) (View Protamin Zinc Insulin Review and Protamin Zinc Insulin Label ), ATROVENT (View Atrovent Review and Atrovent Label ), SERETIDE (Dose: 25/50) (View Seretide Review and Seretide Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

4963203-3 | Hyperkalaemia, Hyponatraemia, Renal Failure Acute
Patient was taking Seguril (View Usage). Patient experienced the following unwanted or unexpected effects: hyperkalaemia, hyponatraemia, renal failure acute on Mar 27, 2006 from Additional patient health information: Female patient , 73 years of age, . Seguril dosage: . During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), AMERIDE (View Ameride Review and Ameride Label ), DIOVAN (View Diovan Review and Diovan Label ), DICLOFENAC (View Diclofenac Review and Diclofenac Label ). Patient was hospitalized.

4963202-1 | Acidosis, Cardiac Arrest, Hyperphosphataemia, Hypocalcaemia, Hypokalaemia, Torsade De Pointes
Adverse event was reported on Mar 27, 2006 by a Male patient taking Seguril (View Usage) (Dosage: ) was diagnosed with hypertensive heart disease, x-ray (What is x-ray?), gastrointestinal disorder, ventricular fibrillation, meningitis bacterial and. Location: , 65 years of age, weighting 176.4 lb, Patient had the following side effects: acidosis, cardiac arrest (What is cardiac arrest?), hyperphosphataemia, hypocalcaemia, hypokalaemia, torsade de pointes. During the same period patient was treated with FOSFOSODA (View Fosfosoda Review and Fosfosoda Label ), ENEMA CASEN (View Enema Casen Review and Enema Casen Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), CEFOTAXIME (View Cefotaxime Review and Cefotaxime Label ). Patient was hospitalized.

4963201-X | Gallbladder Disorder, Hepatitis Cholestatic
on Mar 27, 2006 Male patient from , 50 years of age, weighting 154.3 lb, was diagnosed with renal disorder, anorexia, malignant hypertension, prophylaxis and was treated with Seguril (View Usage). After Seguril was administered, patient had the following side effects: gallbladder disorder, hepatitis cholestatic. Seguril dosage: . During the same period patient was treated with MEGEFREN (View Megefren Review and Megefren Label ), NORVASC (View Norvasc Review and Norvasc Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ).

4944229-2 | Hyperkalaemia, Renal Failure Acute
on Mar 06, 2006 Male patient from , 90 years of age, was treated with Seguril (View Usage). Patient experienced the following unwanted or unexpected effects: hyperkalaemia, renal failure acute. Seguril dosage: . During the same period patient was treated with RENITEC (View Renitec Review and Renitec Label ). Patient was hospitalized.

4906278-X | Renal Failure Acute
Patient was taking Seguril (View Usage). Patient had the following side effects: renal failure acute on Jan 23, 2006 from Additional patient health information: Male patient , 86 years of age, was diagnosed with essential hypertension and. Seguril dosage: . During the same period patient was treated with GOPTEN (View Gopten Review and Gopten Label ). Patient was hospitalized.

4898663-X | Encephalopathy
Adverse event was reported on Jan 23, 2006 by a Male patient taking Seguril (View Usage) (Dosage: ) was diagnosed with oedema and. Location: , 67 years of age, After Seguril was administered, patient had the following side effects: encephalopathy. During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), NITRODERM (View Nitroderm Review and Nitroderm Label ), ASTUDAL (View Astudal Review and Astudal Label ). Patient was hospitalized.

4897449-X | Renal Failure Acute
on Jan 23, 2006 Male patient from , 86 years of age, was diagnosed with essential hypertension and was treated with Seguril (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure acute. Seguril dosage: . During the same period patient was treated with GOPTEN (View Gopten Review and Gopten Label ). Patient was hospitalized.

4860837-1 | Renal Failure Acute
on Dec 09, 2005 Male patient from , 86 years of age, was treated with Seguril (View Usage). Patient had the following side effects: renal failure acute. Seguril dosage: Dose: 40mg/tbl. During the same period patient was treated with ALDACTONE (Dose: 25mg/tbl) (View Aldactone Review and Aldactone Label ), HIGROTON (View Higroton Review and Higroton Label ).

4820902-1 | Atrioventricular Block Complete, Confusional State, Disease Progression, Hepatic Cirrhosis, Hyperkalaemia, Renal Failure Acute
Patient was taking Seguril (View Usage). After Seguril was administered, patient had the following side effects: atrioventricular block complete, confusional state, disease progression, hepatic cirrhosis, hyperkalaemia, renal failure acute on Oct 21, 2005 from Additional patient health information: Male patient , 74 years of age, . Seguril dosage: Dose: Unk. During the same period patient was treated with ALDACTONE (Dose: Unk) (View Aldactone Review and Aldactone Label ), KONAKION (Dose: Unk) (View Konakion Review and Konakion Label ), SPIRIVA (Dose: Unk) (View Spiriva Review and Spiriva Label ), FLUIMUCIL (Dose: Unk) (View Fluimucil Review and Fluimucil Label ), DICLOFENAC (Dose: Unk) (View Diclofenac Review and Diclofenac Label ), NOLOTIL (Dose: Unk) (View Nolotil Review and Nolotil Label ).

4820302-4 | Hyperkalaemia
Adverse event was reported on Oct 21, 2005 by a Male patient taking Seguril (View Usage) (Dosage: ) . Location: , 77 years of age, Patient experienced the following unwanted or unexpected effects: hyperkalaemia. During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ). Patient was hospitalized.

4820301-2 | Hepatic Encephalopathy
on Oct 21, 2005 Male patient from , 62 years of age, was diagnosed with hepatic cirrhosis and was treated with Seguril (View Usage). Patient had the following side effects: hepatic encephalopathy. Seguril dosage: . During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ). Patient was hospitalized.

4819065-8 | Renal Failure Acute
on Oct 21, 2005 Male patient from , 97 years of age, was treated with Seguril (View Usage). After Seguril was administered, patient had the following side effects: renal failure acute. Seguril dosage: . During the same period patient was treated with ACOVIL (View Acovil Review and Acovil Label ), ALDACTACINE (Dose: 0.5 Tablet) (View Aldactacine Review and Aldactacine Label ).

4815524-2 | Hyperkalaemia
Patient was taking Seguril (View Usage). Patient experienced the following unwanted or unexpected effects: hyperkalaemia on Oct 21, 2005 from Additional patient health information: Male patient , 77 years of age, . Seguril dosage: . During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ). Patient was hospitalized.

4815523-0 | Hepatic Encephalopathy
Adverse event was reported on Oct 21, 2005 by a Male patient taking Seguril (View Usage) (Dosage: ) was diagnosed with hepatic cirrhosis and. Location: , 62 years of age, Patient had the following side effects: hepatic encephalopathy. During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ). Patient was hospitalized.

4798221-1 | Atrioventricular Block, Blood Potassium Increased, Blood Pressure Decreased, Confusional State, Dehydration, Disorientation, Gastroenteritis, Haemodynamic Instability, Hyperkalaemia
on Oct 06, 2005 Female patient from , 78 years of age, was diagnosed with oedema and was treated with Seguril (View Usage). After Seguril was administered, patient had the following side effects: atrioventricular block, blood potassium increased, blood pressure decreased, confusional state, dehydration, disorientation, gastroenteritis (What is gastroenteritis?), haemodynamic instability, hyperkalaemia. Seguril dosage: . During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ). Patient was hospitalized.

4772677-2 | Hyperkalaemia, Renal Failure Acute
on Sep 09, 2005 Male patient from , 82 years of age, was treated with Seguril (View Usage). Patient experienced the following unwanted or unexpected effects: hyperkalaemia, renal failure acute. Seguril dosage: . During the same period patient was treated with VALS (View Vals Review and Vals Label ), AMERIDE (View Ameride Review and Ameride Label ).

4743603-7 | Encephalopathy
Patient was taking Seguril (View Usage). Patient had the following side effects: encephalopathy on Aug 03, 2005 from Additional patient health information: Male patient , 52 years of age, was diagnosed with chronic hepatitis, prophylaxis, constipation (What is constipation?), diabetes mellitus and. Seguril dosage: . During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), SOLGOL (View Solgol Review and Solgol Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), CORONUR (View Coronur Review and Coronur Label ), MIXTARD HUMAN 70/30 (Dose: 100ui/10ml) (View Mixtard Human 70/30 Review and Mixtard Human 70/30 Label ). Patient was hospitalized.

4718332-6 | Hypokalaemia, Hyponatraemia, Renal Impairment
Adverse event was reported on Jul 06, 2005 by a Male patient taking Seguril (View Usage) (Dosage: ) was diagnosed with oedema, brain neoplasm, chronic obstructive pulmonary disease and. Location: , 81 years of age, After Seguril was administered, patient had the following side effects: hypokalaemia, hyponatraemia, renal impairment. During the same period patient was treated with INDAPAMIDE (View Indapamide Review and Indapamide Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), VENTOLIN (View Ventolin Review and Ventolin Label ), ATROVENT (View Atrovent Review and Atrovent Label ), SERETIDE (View Seretide Review and Seretide Label ). Patient was hospitalized.

4716054-9 | Encephalopathy, Hyponatraemia, Liver Disorder
on Jul 06, 2005 Male patient from , 49 years of age, was diagnosed with chronic hepatitis, hiv infection (What is hiv infection?) and was treated with Seguril (View Usage). Patient experienced the following unwanted or unexpected effects: encephalopathy, hyponatraemia, liver disorder. Seguril dosage: . During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), COMBIVIR (View Combivir Review and Combivir Label ). Patient was hospitalized.

4711099-7 | Pneumonitis, Rash Erythematous
on Jun 28, 2005 Female patient from , 68 years of age, weighting 154.3 lb, was diagnosed with essential hypertension, epilepsy (What is epilepsy?), brain neoplasm, prophylaxis against gastrointestinal ulcer and was treated with Seguril (View Usage). Patient had the following side effects: pneumonitis, rash erythematous. Seguril dosage: . During the same period patient was treated with PHENYTOIN (View Phenytoin Review and Phenytoin Label ), TENORMIN (View Tenormin Review and Tenormin Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

4708296-3 | Encephalopathy
Patient was taking Seguril (View Usage). After Seguril was administered, patient had the following side effects: encephalopathy on Jun 28, 2005 from Additional patient health information: Female patient , 77 years of age, was diagnosed with hepatic cirrhosis, prophylaxis and. Seguril dosage: . During the same period patient was treated with SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

4705121-1 | Renal Failure Acute
Adverse event was reported on Jun 21, 2005 by a Female patient taking Seguril (View Usage) (Dosage: ) was diagnosed with oedema, respiratory disorder and. Location: , 86 years of age, Patient experienced the following unwanted or unexpected effects: renal failure acute. During the same period patient was treated with ATROVENT (Dose: 500ug/2ml 100) (View Atrovent Review and Atrovent Label ), VENTOLIN (Dose: 0.5 % 10ml) (View Ventolin Review and Ventolin Label ), URBASON (Dose: 40mg 100) (View Urbason Review and Urbason Label ), TAVANIC (Dose: 5mg/ml 100ml) (View Tavanic Review and Tavanic Label ). Patient was hospitalized.

4705120-X | Renal Failure Acute
on Jun 21, 2005 Female patient from , 93 years of age, was diagnosed with myocardial ischaemia, essential hypertension, atrial fibrillation (What is atrial fibrillation?) and was treated with Seguril (View Usage). Patient had the following side effects: renal failure acute. Seguril dosage: . During the same period patient was treated with CAPOTEN (View Capoten Review and Capoten Label ), MASDIL (View Masdil Review and Masdil Label ). Patient was hospitalized.

4705118-1 | Syncope
on Jun 21, 2005 Male patient from , 91 years of age, was diagnosed with left ventricular failure, hypertensive nephropathy and was treated with Seguril (View Usage). After Seguril was administered, patient had the following side effects: syncope. Seguril dosage: . During the same period patient was treated with EMCONCOR (View Emconcor Review and Emconcor Label ), LOSARTAN (View Losartan Review and Losartan Label ), TROMALYT (View Tromalyt Review and Tromalyt Label ), LABILENO (View Labileno Review and Labileno Label ). Patient was hospitalized.

4673241-6 | Encephalopathy
Patient was taking Seguril (View Usage). Patient experienced the following unwanted or unexpected effects: encephalopathy on May 13, 2005 from Additional patient health information: Female patient , 72 years of age, was diagnosed with oedema, iron deficiency anaemia, essential hypertension, liver transplant (What is liver transplant?), depression (What is depression?) and. Seguril dosage: . During the same period patient was treated with NEORECORMON (Dose: 300 Ur) (View Neorecormon Review and Neorecormon Label ), CARDURAN NEO (View Carduran Neo Review and Carduran Neo Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), PROGRAF (View Prograf Review and Prograf Label ), TRYPTIZOL (View Tryptizol Review and Tryptizol Label ). Patient was hospitalized.

4627821-4 | Hyperkalaemia
Adverse event was reported on Mar 29, 2005 by a Male patient taking Seguril (View Usage) (Dosage: ) was diagnosed with renal failure chronic, cardiac disorder and. Location: , 64 years of age, Patient had the following side effects: hyperkalaemia. During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), NORVASC (View Norvasc Review and Norvasc Label ), SINTROM (View Sintrom Review and Sintrom Label ). Patient was hospitalized.

4618992-4 | Blood Sodium Decreased, Encephalopathy, Hyperkalaemia, Laboratory Test Abnormal
on Mar 15, 2005 Male patient from , 72 years of age, was diagnosed with hepatic cirrhosis, arrhythmia (What is arrhythmia?), iron deficiency anaemia, prophylaxis and was treated with Seguril (View Usage). After Seguril was administered, patient had the following side effects: blood sodium decreased, encephalopathy, hyperkalaemia, laboratory test abnormal. Seguril dosage: . During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), TARDYFERON (View Tardyferon Review and Tardyferon Label ), NOROXIN (View Noroxin Review and Noroxin Label ), DUPHALAC (View Duphalac Review and Duphalac Label ). Patient was hospitalized.

4598351-3 | Renal Failure Acute
on Feb 21, 2005 Male patient from , 84 years of age, was diagnosed with brain oedema and was treated with Seguril (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure acute. Seguril dosage: . Patient was hospitalized.

4575470-9 | Hepatic Encephalopathy
Patient was taking Seguril (View Usage). Patient had the following side effects: hepatic encephalopathy on Feb 03, 2005 from Additional patient health information: Male patient , 58 years of age, . Seguril dosage: . During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), NORFLOXACIN (View Norfloxacin Review and Norfloxacin Label ), SUMIAL (View Sumial Review and Sumial Label ), OPIREN (View Opiren Review and Opiren Label ), DUPHALAC (View Duphalac Review and Duphalac Label ).